[go: up one dir, main page]

MX2019004554A - Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada. - Google Patents

Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.

Info

Publication number
MX2019004554A
MX2019004554A MX2019004554A MX2019004554A MX2019004554A MX 2019004554 A MX2019004554 A MX 2019004554A MX 2019004554 A MX2019004554 A MX 2019004554A MX 2019004554 A MX2019004554 A MX 2019004554A MX 2019004554 A MX2019004554 A MX 2019004554A
Authority
MX
Mexico
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
guar gum
Prior art date
Application number
MX2019004554A
Other languages
English (en)
Inventor
Muldoon Brendan
Sweeney Gerarde
Karen Boyd Emma
Gerald Loughlin Ryan
Original Assignee
Warner Chilcott Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co Llc filed Critical Warner Chilcott Co Llc
Publication of MX2019004554A publication Critical patent/MX2019004554A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una forma de dosis farmacéutica de gelatina blanda que incluye (a) una cubierta que incluye gelatina; y (b) un relleno que incluye al menos un ingrediente activo, uno o más polietilenglicoles, y una goma de guar modificada. La forma de dosis farmacéutica de gelatina blanda mantiene su integridad (dureza) de cubierta y viscosidad de relleno después del almacenamiento.
MX2019004554A 2013-03-15 2015-09-09 Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada. MX2019004554A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361794906P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
MX2019004554A true MX2019004554A (es) 2019-08-05

Family

ID=50588879

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015012057A MX364440B (es) 2013-03-15 2014-03-14 Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.
MX2019004554A MX2019004554A (es) 2013-03-15 2015-09-09 Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015012057A MX364440B (es) 2013-03-15 2014-03-14 Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.

Country Status (14)

Country Link
US (3) US9795569B2 (es)
EP (2) EP3187170A1 (es)
JP (3) JP6335270B2 (es)
KR (1) KR20150131070A (es)
CN (2) CN111374959A (es)
AU (2) AU2014239994B2 (es)
BR (1) BR112015022946A8 (es)
CA (1) CA2906633C (es)
ES (1) ES2619121T3 (es)
HK (1) HK1218622A1 (es)
IL (1) IL241377B (es)
MX (2) MX364440B (es)
RU (1) RU2676480C2 (es)
WO (1) WO2014152269A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1218622A1 (zh) * 2013-03-15 2017-03-03 Warner Chilcott Company, Llc 含有改性瓜尔胶的药物软明胶胶囊剂型
EP3273948B1 (en) 2015-03-26 2020-02-12 Patheon Softgels Inc. Liquisoft capsules
JP2017214299A (ja) * 2016-05-30 2017-12-07 ライオン株式会社 半固形製剤及びその製造方法
CA3201467A1 (en) * 2020-11-13 2022-05-19 Pfizer Inc. Talazoparib soft gelatin capsule dosage form
CN116916895A (zh) * 2020-11-13 2023-10-20 辉瑞公司 他拉唑帕尼软明胶胶囊剂型
CN116531444B (zh) * 2023-07-06 2023-10-10 健码制药（广东）有限公司 镇咳清肺软胶囊及其制备工艺

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
FR2739558B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US5989535A (en) 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (es) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
FR2843304B1 (fr) * 2002-08-07 2005-12-16 Ricarimpex Extraits de sangsues pour stents
EP1599485A2 (en) 2003-02-18 2005-11-30 Ranbaxy Laboratories, Ltd. Podophyllotoxin derivatives as antitumor agents
KR100570450B1 (ko) * 2003-09-25 2006-04-12 한국유나이티드제약 주식회사 가용성 로바스타틴의 연질캡슐제 조성물 및 그의 제조방법
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
US7067504B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
EP1709060A1 (en) 2004-01-15 2006-10-11 Warner Chilcott Company Inc. Di-steroidal prodrugs of estradiol
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
US10016442B2 (en) 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
EP2390260B1 (en) 2005-07-12 2014-09-17 Warner Chilcott Company, LLC Ester derivative of ethinyl estradiol
CN101228177A (zh) 2005-07-12 2008-07-23 沃纳奇尔科特公司 雌二醇的3-酯前药
US7468970B2 (en) 2005-10-24 2008-12-23 Honeywell International Inc. Routing of mobile agents in a network
WO2007050975A2 (en) * 2005-10-26 2007-05-03 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
US20070104778A1 (en) 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
WO2007066837A1 (en) 2005-12-06 2007-06-14 Lg Household & Health Care Ltd. Delivery system for tooth whitening component using in situ gelling
EP1986591A1 (en) 2006-02-10 2008-11-05 LG Household & Health Care Ltd. In-situ melting and gelling tablet composition for oral care
US20080090569A1 (en) 2006-10-13 2008-04-17 At&T Knowledge Ventures, L.P. Method and apparatus for performing signal processing in an ip multimedia subsystem network
US20080122993A1 (en) 2006-11-29 2008-05-29 Sanyo Electric Co., Ltd. Television image receiver
MX2009007913A (es) 2007-01-25 2009-07-31 Panacea Biotec Ltd Composicion farmaceutica de liberacion modificada y un procedimiento para elaborarla.
WO2008122993A1 (en) 2007-04-09 2008-10-16 Panacea Biotec Limited Controlled release formulation of coated microparticles
WO2009119979A2 (ko) 2008-03-26 2009-10-01 크루셜텍(주) 광 포인팅장치 및 이를 갖는 휴대 전자기기
CN101474167A (zh) * 2009-01-23 2009-07-08 西安德天药业股份有限公司 雌二醇阴道用胶囊的制备方法
US20110003000A1 (en) 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
HK1218622A1 (zh) * 2013-03-15 2017-03-03 Warner Chilcott Company, Llc 含有改性瓜尔胶的药物软明胶胶囊剂型

Also Published As

Publication number Publication date
CA2906633C (en) 2021-11-30
US20150044285A1 (en) 2015-02-12
RU2676480C2 (ru) 2018-12-29
BR112015022946A2 (pt) 2017-07-18
JP2016513684A (ja) 2016-05-16
ES2619121T3 (es) 2017-06-23
US9795569B2 (en) 2017-10-24
CN105307634A (zh) 2016-02-03
JP6335270B2 (ja) 2018-05-30
RU2015137612A (ru) 2017-04-24
JP6704430B2 (ja) 2020-06-03
KR20150131070A (ko) 2015-11-24
AU2019200116A1 (en) 2019-01-31
NZ712280A (en) 2021-01-29
JP2020147569A (ja) 2020-09-17
CN105307634B (zh) 2020-03-10
HK1218622A1 (zh) 2017-03-03
US10744096B2 (en) 2020-08-18
CA2906633A1 (en) 2014-09-25
MX364440B (es) 2019-04-26
WO2014152269A1 (en) 2014-09-25
IL241377B (en) 2019-08-29
US20140271838A1 (en) 2014-09-18
BR112015022946A8 (pt) 2022-11-29
AU2014239994A1 (en) 2015-10-08
MX2015012057A (es) 2016-05-05
EP2950781B1 (en) 2016-12-21
JP2018140998A (ja) 2018-09-13
IL241377A0 (en) 2015-11-30
CN111374959A (zh) 2020-07-07
US20180036252A1 (en) 2018-02-08
EP3187170A1 (en) 2017-07-05
US9820946B2 (en) 2017-11-21
AU2014239994B2 (en) 2019-01-24
EP2950781A1 (en) 2015-12-09

Similar Documents

Publication Publication Date Title
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
MX2015011163A (es) Capsula entericas blandas que no contienen gelatina.
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
MX2019002575A (es) Microcapsulas biodegradables que contienen material de relleno.
MX2015008069A (es) Conjunto de envasado para dispositivos de administracion de farmacos.
GEP20217243B (en) Orodispersible dosage unit containing an estetrol component
PE20181095A1 (es) Envase blister
EP3384891A4 (en) MEDICAMENT CARTET, DRUG DELIVERY AND MEDICAMENT PACKAGING DEVICE
MX2016003754A (es) Una composicion farmaceutica estable que contiene amlodipina y valsartan.
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
MX2018001655A (es) Sistema para control de la humedad que comprende un paquete humectante relleno con material humectante que comprende glicerol y agua.
HK1220113A1 (zh) 药物软明胶胶囊剂型
EP3318217A4 (en) PROTHESIS PACKAGING, PROSTHESIS AND PROSTHESIS WITH PACKAGING
MX2018001221A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
IN2013MU03370A (es)
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
MX2018001223A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
MX2018001222A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
IN2014MU00043A (es)
GEAP201914507A (en) Pharmaceutical composition comprising bisoprolol and perindoril
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
GB2576446B (en) Shape memory alloy based drug delivery device
IN2013MU02015A (es)
WO2013144976A3 (en) Chewable soft gelatin capsule dosage form of mucolytic agents